These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 31888670)

  • 21. [Diagnostic Efficacy of SHOX2 Gene Hypermethylation for Lung Cancer: A Meta-Analysis].
    Liu Q; Wang S; Pei G; Yang Y; Huang Y
    Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):490-496. PubMed ID: 34275516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Clinical Significance of Serum MASP-2 and IDH1 in the Early Diagnosis of Non-Small Cell Lung Cancer.
    Chen Y; Wu ED; Ma S; Bai WQ; Yin YJ; Shi GL
    Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter hypermethylation of
    Branchi V; Schaefer P; Semaan A; Kania A; Lingohr P; Kalff JC; Schäfer N; Kristiansen G; Dietrich D; Matthaei H
    Clin Epigenetics; 2016; 8():133. PubMed ID: 27999621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta-analysis update.
    Zhou X; Lu X; Wu H; Liu J; Huang H
    Thorac Cancer; 2021 Dec; 12(24):3327-3332. PubMed ID: 34741433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
    Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
    J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological Significance and Diagnostic Value of DLEC1 Hypermethylation in Lung Cancer: A Meta-analysis.
    Li X; Mao W; Guo D; Xu H
    J Nippon Med Sch; 2019; 86(2):62-69. PubMed ID: 31130567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
    Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
    J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An epigenetic classifier for early stage lung cancer.
    Su Y; Fang HB; Jiang F
    Clin Epigenetics; 2018; 10():68. PubMed ID: 29796119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of diagnostic performance in lung cancers by combining CEA and CA125 with autoantibodies detection.
    Zang R; Li Y; Jin R; Wang X; Lei Y; Che Y; Lu Z; Mao S; Huang J; Liu C; Zheng S; Zhou F; Wu Q; Gao S; Sun N; He J
    Oncoimmunology; 2019; 8(10):e1625689. PubMed ID: 31646071
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma.
    Zhao J; Lu Y; Ren X; Bian T; Feng J; Sun H; Liu L; She B; Liu Y; Ke H
    BMC Cancer; 2024 Jun; 24(1):687. PubMed ID: 38840077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.
    Grasse S; Lienhard M; Frese S; Kerick M; Steinbach A; Grimm C; Hussong M; Rolff J; Becker M; Dreher F; Schirmer U; Boerno S; Ramisch A; Leschber G; Timmermann B; Grohé C; Lüders H; Vingron M; Fichtner I; Klein S; Odenthal M; Büttner R; Lehrach H; Sültmann H; Herwig R; Schweiger MR
    Genome Med; 2018 Jul; 10(1):55. PubMed ID: 30029672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of exfoliated tumor cells combined with DNA methylation in bronchoalveolar lavage fluid for lung cancer.
    Lu H; Lin D
    Medicine (Baltimore); 2023 Sep; 102(36):e34955. PubMed ID: 37682182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined detection of SHOX2 and PTGER4 methylation with serum marker CYFRA21-1 for improved diagnosis of malignant pleural mesothelioma.
    Zhang N; Li Y; Sun Z; Dong Y; Zhou L; Zhang C; Liu Z; Zhang Q; Li K; Xu F; Zhang L; She B; Ren X; Che N
    J Clin Pathol; 2024 Jul; ():. PubMed ID: 39060112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
    Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
    PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
    Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
    Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and Validation of a Lung Cancer Diagnostic Model Based on 6-Gene Methylation Frequency in Blood, Clinical Features, and Serum Tumor Markers.
    Kang C; Wang D; Zhang X; Wang L; Wang F; Chen J
    Comput Math Methods Med; 2021; 2021():9987067. PubMed ID: 34257703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer.
    Nikolaidis G; Raji OY; Markopoulou S; Gosney JR; Bryan J; Warburton C; Walshaw M; Sheard J; Field JK; Liloglou T
    Cancer Res; 2012 Nov; 72(22):5692-701. PubMed ID: 22962272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings.
    Liew PL; Huang RL; Wu TI; Liao CC; Chen CW; Su PH; Wang HC; Weng YC; Lai HC
    Clin Epigenetics; 2019 Nov; 11(1):170. PubMed ID: 31779688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates.
    Dietrich D; Kneip C; Raji O; Liloglou T; Seegebarth A; Schlegel T; Flemming N; Rausch S; Distler J; Fleischhacker M; Schmidt B; Giles T; Walshaw M; Warburton C; Liebenberg V; Field JK
    Int J Oncol; 2012 Mar; 40(3):825-32. PubMed ID: 22108652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
    Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
    J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.